|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
3 months to Dec 31, 2020
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | |||
| Right-of-use asset amortization | |||
| Stock-based compensation, net of amounts capitalized | |||
| Change in fair value of warrants | |||
| Net amortization of premiums and accretion of discounts on investments | |||
| Amortization of debt discount | |||
| Change in fair value of derivative liability | |||
| Loss of sale of property, plant and equipment | |||
| Issuance of common stock for services | |||
| Changes in operating assets and liabilities: | |||
| Accrued expenses | |||
| Prepaid expenses and other current assets | |||
| Other assets | |||
| Accounts payable | |||
| Other long-term liabilities | |||
| Operating lease liabilities | |||
| Accrued expenses and other current liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities | |||
| Proceeds from promissory note — related party | |||
| Payment of offering costs | |||
| Maturities of investments | |||
| Purchase of property, equipment and software | |||
| Proceeds from sale of property, plant and equipment | |||
| Deposit for purchase of trucks | |||
| Refund of deposit for trucks | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities | |||
| Cash proceeds received from convertible note payable | |||
| Proceeds from NGA recapitalization | |||
| Transaction costs related to merger with NGA | |||
| Payment towards notes payable | |||
| Proceeds from exercise of stock options | |||
| Repurchase of early exercised options | |||
| Net cash provided by financing activities | |||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||
| Cash – Beginning | |||
| Cash – Ending | |||
| Cash, cash equivalents and restricted cash at beginning of period | |||
| Cash, cash equivalents and restricted cash at end of period | |||
| Supplemental disclosures of cash flow information: | |||
| Cash paid during the year for interest | |||
| Supplemental schedule of noncash investing and financing activities | |||
| Deferred offering costs included in accrued offering costs | |||
| Deferred offering costs paid by Sponsor in exchange for the issuance of common stock | |||
| Convertible notes converted into shares of Class A common stock upon consummation of Business Combination | |||
| Derivative liability converted into shares of Class A common stock upon consummation of Business Combination | |||
| Warrants converted into shares of Class A common stock upon consummation of Business Combination | |||
| Right-of-use assets obtained in exchange for lease obligations | |||
| Issuance of common stock for services | |||
| Acquisition of property, equipment and software in accounts payable | |||
| Acquisition of trucks by assuming notes payable | |||
| Stock-based compensation capitalized into internally developed software | |||
| Vesting of early exercised stock options |
Loading...